JIN MEDICAL Market Risk Adjusted Performance
| ZJYL Stock | | | 0.12 -0.02 -14.29% |
JIN MEDICAL market risk adjusted performance lookup summarizes this and related technical indicators for JIN MEDICAL INTERNATIONAL. Coverage varies by data normalization and availability; see
Equity Screeners for broader screening context. JIN MEDICAL has a market cap of 923.63 K, operating margin of 9.83%, ROE of 4.75%. Use
Your Current Watchlist to explore allocation context. This includes a position in JIN MEDICAL INTERNATIONAL within the portfolio mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in small area income & poverty estimates.
JIN MEDICAL INTERNATIONAL has current Market Risk Adjusted Performance of
-0.32.
MRAP | = | ER[a] + (1/BETA - 1) | X | ER[a] - RFR) |
| = | -0.32 | |
| ER[a] | = | Expected return on investing in JIN MEDICAL |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
| BETA | = | Beta of the asset with market or selected benchmark. |
JIN MEDICAL Market Risk Adjusted Performance Peers Comparison
JIN Market Risk Adjusted Performance Relative To Other Indicators
JIN MEDICAL INTERNATIONAL is rated
below average for market risk adjusted performance within its peer group. It is currently under evaluation for maximum drawdown within its peer group .
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.